Reddy EP, Reynolds RK, Santos E, Barbacid M (November 1982). "A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene". Nature. 300 (5888): 149–152. Bibcode:1982Natur.300..149R. doi:10.1038/300149a0. PMID7133135. S2CID34599264.
Esquela-Kerscher A, Slack FJ (April 2006). "Oncomirs - microRNAs with a role in cancer". Nature Reviews. Cancer. 6 (4): 259–269. doi:10.1038/nrc1840. PMID16557279. S2CID10620165.
Gschwind A, Fischer OM, Ullrich A (May 2004). "The discovery of receptor tyrosine kinases: targets for cancer therapy". Nature Reviews. Cancer. 4 (5): 361–370. doi:10.1038/nrc1360. PMID15122207. S2CID6939454.
Thomas SM, Brugge JS (1 November 1997). "Cellular functions regulated by Src family kinases". Annual Review of Cell and Developmental Biology. 13 (1): 513–609. doi:10.1146/annurev.cellbio.13.1.513. PMID9442882.
Czernilofsky AP, Levinson AD, Varmus HE, Bishop JM, Tischer E, Goodman HM (September 1980). "Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product". Nature. 287 (5779): 198–203. Bibcode:1980Natur.287..198C. doi:10.1038/287198a0. PMID6253794. S2CID4231060.
Reddy EP, Reynolds RK, Santos E, Barbacid M (November 1982). "A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene". Nature. 300 (5888): 149–152. Bibcode:1982Natur.300..149R. doi:10.1038/300149a0. PMID7133135. S2CID34599264.
Reddy EP, Reynolds RK, Santos E, Barbacid M (November 1982). "A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene". Nature. 300 (5888): 149–152. Bibcode:1982Natur.300..149R. doi:10.1038/300149a0. PMID7133135. S2CID34599264.
Esquela-Kerscher A, Slack FJ (April 2006). "Oncomirs - microRNAs with a role in cancer". Nature Reviews. Cancer. 6 (4): 259–269. doi:10.1038/nrc1840. PMID16557279. S2CID10620165.
Press RD, Misra A, Gillaspy G, Samols D, Goldthwait DA (June 1989). "Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1". Cancer Research. 49 (11): 2914–2920. PMID2655888.
Gschwind A, Fischer OM, Ullrich A (May 2004). "The discovery of receptor tyrosine kinases: targets for cancer therapy". Nature Reviews. Cancer. 4 (5): 361–370. doi:10.1038/nrc1360. PMID15122207. S2CID6939454.
Thomas SM, Brugge JS (1 November 1997). "Cellular functions regulated by Src family kinases". Annual Review of Cell and Developmental Biology. 13 (1): 513–609. doi:10.1146/annurev.cellbio.13.1.513. PMID9442882.
Reddy EP, Reynolds RK, Santos E, Barbacid M (November 1982). "A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene". Nature. 300 (5888): 149–152. Bibcode:1982Natur.300..149R. doi:10.1038/300149a0. PMID7133135. S2CID34599264.
Esquela-Kerscher A, Slack FJ (April 2006). "Oncomirs - microRNAs with a role in cancer". Nature Reviews. Cancer. 6 (4): 259–269. doi:10.1038/nrc1840. PMID16557279. S2CID10620165.
Gschwind A, Fischer OM, Ullrich A (May 2004). "The discovery of receptor tyrosine kinases: targets for cancer therapy". Nature Reviews. Cancer. 4 (5): 361–370. doi:10.1038/nrc1360. PMID15122207. S2CID6939454.